Citation Impact
Citing Papers
Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7
2021 StandoutNobel
Modulation of immune cell reactivity with cis -binding Siglec agonists
2021 StandoutNobel
Extracellular vesicles and particles impact the systemic landscape of cancer
2022
Targeted glycan degradation potentiates the anticancer immune response in vivo
2020 StandoutNobel
Siglecs and their roles in the immune system
2007 Standout
I-type lectins
2002
The past and future of CD33 as therapeutic target in acute myeloid leukemia
2014
Glycosylation in Cellular Mechanisms of Health and Disease
2006 Standout
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Kidney stones
2016
Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
2017 Standout
Cancer stem cells revisited
2017 Standout
Biological roles of glycans
2016 Standout
Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion
2013 StandoutNobel
Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell–cell interactions and signalling
2002
P-type lectins
2002
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Imaging the Sialome during Zebrafish Development with Copper‐Free Click Chemistry
2012 StandoutNobel
Negative Regulation of T Cell Receptor Signaling by Siglec-7 (p70/AIRM) and Siglec-9
2004
Synthesis and Microcontact Printing of Dual End‐Functionalized Mucin‐like Glycopolymers for Microarray Applications
2009 StandoutNobel
Glycan Array Screening Reveals a Candidate Ligand for Siglec-8*
2004
Basic and Clinical Immunology of Siglecs
2008
Siglecs—the major subfamily of I-type lectins
2005
Roles of N-Linked Glycans in the Endoplasmic Reticulum
2004 Standout
Synthesis and Microcontact Printing of Dual End‐Functionalized Mucin‐like Glycopolymers for Microarray Applications
2009 StandoutNobel
The Genetics of Alzheimer’s Disease
2012
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Kidney Stone Disease: An Update on Current Concepts
2018 Standout
Works of Michael Ordon being referenced
Cloning and Molecular Characterization of Two Splice Variants of a New Putative Member of the Siglec-3-like Subgroup of Siglecs
2001
Exosomal MicroRNAs Are Diagnostic Biomarkers and Can Mediate Cell–Cell Communication in Renal Cell Carcinoma
2015
Genomic organization of the siglec gene locus on chromosome 19q13.4 and cloning of two new siglec pseudogenes
2002
The Surgical Management of Kidney Stone Disease: A Population Based Time Series Analysis
2014
A Population Based Study of the Changing Demographics of Patients Undergoing Definitive Treatment for Kidney Stone Disease
2014
Molecular Characterization, Tissue Expression, and Mapping of a Novel Siglec-like Gene (SLG2) with Three Splice Variants
2001